C77.3

Secondary and unspecified malignant neoplasm of axillary and upper limb lymph nodes

Secondary malignant neoplasm of the axillary and upper limb lymph nodes (C77.3) identifies a condition where cancer has metastasized to the lymphatic system within the armpit and arm from a primary site located elsewhere in the body. The axillary lymph node basin is a major drainage site for several anatomical regions, most notably the breast, the chest wall, and the upper extremities. As such, the most common primary source for malignancy in these nodes is invasive breast carcinoma. Other significant primary origins include cutaneous melanoma of the upper limb or trunk, squamous cell carcinomas of the skin, and occasionally, metastatic spread from primary lung cancer or soft tissue sarcomas. The clinical identification of nodal involvement is a critical component of oncological staging (TNM), as the number and level of involved nodes significantly influence the prognosis, the decision for surgical axillary lymph node dissection, and the selection of adjuvant systemic and regional radiation therapies.

Clinical Symptoms

  • Palpable, firm-to-hard mass in the axilla (armpit)
  • Painless or tender lymphadenopathy in the upper limb
  • Lymphedema (swelling) of the ipsilateral arm or hand
  • Visible fullness or bulging in the axillary region
  • Skin changes over the nodes, such as tethering or peau d'orange
  • Numbness or paresthesia in the arm due to brachial plexus compression
  • Shoulder discomfort or restricted range of motion
  • Enlarged epitrochlear nodes (near the elbow)
  • Unexplained weight loss and fatigue

Common Causes

  • Metastasis from primary breast adenocarcinoma (most common)
  • Metastatic malignant melanoma from the arm, shoulder, or upper back
  • Cutaneous squamous cell or basal cell carcinoma of the upper extremity
  • Direct lymphatic spread from soft tissue sarcomas of the limb
  • Metastasis from primary lung neoplasms (less frequent)
  • Metastasis from Merkel cell carcinoma
  • Occult primary malignancy with initial presentation in axillary nodes

Documentation & Coding Tips

Specify laterality for all axillary lymph node involvements.

Example: Patient with biopsy-confirmed metastatic adenocarcinoma to the right axillary lymph nodes. The primary site is the right breast, upper-outer quadrant. BillingFocus: Laterality (right) and primary site linkage (C50.411). RiskAdjustment: Assigns HCC 10 for metastatic cancer and HCC 12 for breast cancer, significantly impacting the risk score.

Billing Focus: Documentation must specify right, left, or bilateral axillary involvement to satisfy specificity requirements for C77.3.

Always document the primary malignancy site in conjunction with the secondary node code.

Example: Documentation confirms secondary malignant neoplasm of the left axillary lymph nodes (C77.3) resulting from a primary malignant melanoma of the left upper arm (C43.62). BillingFocus: Coding both the secondary (C77.3) and the primary (C43.62) codes. RiskAdjustment: Multi-site involvement indicates advanced staging and increases patient complexity levels.

Billing Focus: Sequencing depends on the reason for the encounter; if treating the metastasis, C77.3 may be primary, but the primary site must still be coded.

Distinguish between active secondary neoplasm and history of malignancy.

Example: Patient is undergoing active taxane-based chemotherapy for secondary malignant neoplasm of bilateral axillary lymph nodes (C77.3). BillingFocus: Use active C-codes rather than Z-codes for patients receiving active treatment. RiskAdjustment: Active cancer status (HCC 10) carries significantly more weight than history of status (Z85.x).

Billing Focus: Ensures the encounter is billed as an active cancer treatment episode rather than a surveillance or history-of visit.

Document the specific node groups within the axilla if possible.

Example: Palpable Level II and Level III axillary lymph nodes on the left side, confirmed as secondary malignant neoplasms via PET/CT, secondary to primary lung adenocarcinoma. BillingFocus: Identifies specific anatomical depth for potential surgical planning (38745 vs 38740). RiskAdjustment: Greater nodal burden (Level III) correlates with higher severity and resource utilization.

Billing Focus: Assists in justifying more extensive lymphadenectomy procedures (CPT 38745) over superficial ones (38740).

Identify the primary source even if it is currently unknown.

Example: Malignant neoplasm of right axillary lymph nodes, secondary to adenocarcinoma of unknown primary origin. BillingFocus: Requires C77.3 and C80.1 (Malignant neoplasm of unspecified site). RiskAdjustment: Metastasis from an unknown primary still triggers HCC 10, recognizing the severe systemic nature of the disease.

Billing Focus: Avoids using only an unspecified primary code; ensures the nodal involvement (C77.3) is captured as the definitive secondary site.

Relevant CPT Codes

Related Diagnoses

Hierarchy